Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
53%
Intubation
50%
Otolaryngology
47%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
46%
Overall Survival
43%
Functional Outcome
42%
Head-and-neck
37%
Advanced Laryngeal Cancer
33%
Patients with COVID-19
33%
Radiotherapy
33%
High-risk Human Papillomavirus (HR-HPV)
33%
Confidence Interval
30%
Survival Outcomes
26%
United States
25%
Survivorship
25%
Otolaryngologist
25%
COVID-19 Pandemic
24%
COVID-19 Patients
24%
Trachea
21%
Otolaryngology Residency Programs
20%
Comfort Level
20%
Provider Comfort
20%
Comorbidity
20%
Prognostic Factors
20%
Sinonasal Adenoid Cystic Carcinoma
16%
Intraoperative Parathyroid Hormone Monitoring
16%
Vertical Division
16%
Perceived Impact
16%
Otolaryngology Residency
16%
Osteosarcoma
16%
Mandibular Osteoradionecrosis
16%
Treatment Survival
16%
Oropharyngeal Hemorrhage
16%
Life-cycle Model
16%
Rapid Cycle
16%
Tracheomalacia
16%
Dynamic Risk Model
16%
Chronic Esophageal Foreign Body
16%
Treatment Trends
16%
Irradiated Patients
16%
Simulation Training
16%
Telephone Interview for Cognitive Status
16%
Functional Survival
16%
Score Reporting
16%
Skull Base
16%
Prognostic Survival
16%
Laryngeal Squamous Cell Carcinoma
16%
COVID-19 Impact
16%
Idiopathic Intracranial Hypertension
16%
Home Institutions
16%
Medicine and Dentistry
COVID-19
100%
Overall Survival
55%
Otorhinolaryngology
53%
Intubation
53%
Oropharynx Squamous Cell Carcinoma
39%
Laryngeal Cancer
38%
Wart Virus
33%
Radiation Therapy
28%
Esophagus
20%
Comorbidity
20%
Prognostic Factor
20%
Survival Rate
20%
Neck
19%
Trachea
19%
Diseases
17%
Cylindroma
16%
Larynx Squamous Cell Carcinoma
16%
Surgical Approach
16%
Tinnitus
16%
Hypercalcaemia
16%
Simulation Training
16%
Idiopathic Intracranial Hypertension
16%
Osteosarcoma
16%
Outpatient
16%
Charlson Comorbidity Index
16%
Division
16%
Sensorineural Hearing Loss
16%
Survival Analysis
16%
Bone Necrosis
16%
Parotidectomy
16%
Head and Neck Cancer
16%
Parathyroid
16%
Tracheal Agenesis
16%
Odds Ratio
16%
Parathyroid Hormone
16%
Tracheomalacia
16%
Esophagus Foreign Body
16%
Squamous Cell Carcinoma
16%
Neoadjuvant Chemotherapy
14%
Laryngectomy
14%
Neoplasm
14%
Hearing Impairment
13%
Program Director
12%
Disease Specific Survival
12%
Recurrent Disease
12%
Fistula
11%
Disease Free Survival
11%
Long Term Survival
11%
Calcitonin Gene Related Peptide
10%
Plummer-Vinson Syndrome
10%
